Skip to navigation Skip to content Skip to subnav
Searching 2017-2018 Session

2017-2018 Session

Change Session
Select a session

2007-2008 and Earlier Sessions

S.175 (Act 133)

An act relating to the wholesale importation of prescription drugs into Vermont

Sen. Timothy Ashe, Sen. Claire Ayer, Sen. Virginia Lyons, Sen. Christopher Pearson, Sen. Michael Sirotkin
5/16/2018 - Signed by Governor on May 16, 2018
Sponsor(s)
Last Recorded Action
Senate 5/16/2018 - Signed by Governor on May 16, 2018
Bill/Resolution Text

NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.

An act relating to the wholesale importation of prescription drugs into Vermont

Detailed Status

2017-2018 Legislative Session
Body Date Journal Calendar Location Full Status
An act relating to the wholesale importation of prescription drugs into Vermont

Roll Call History

2017-2018 Legislative Session
Body Date Journal Location Full Status

Back to top

Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.

An act relating to the wholesale importation of prescription drugs into Vermont

Committee Meetings

2017-2018 Legislative Session
Meeting Date Committee
An act relating to the wholesale importation of prescription drugs into Vermont

Meeting Full List

2017-2018 Legislative Session
Thursday, January 18, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sen. Tim Ashe, Sponsor
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Peter Welch, U.S. Congressman, Vermont
John Tracy, Field Representative, Office of Senator Patrick Leahy
Trish Riley, Executive Director, National Academy of State Health Policy

Friday, January 26, 2018
Committee(s):
Senate Committee on Health and Welfare
9:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Kevin Mullin, Chair, Green Mountain Care Board
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
Mark Hage, Member Benefits Director, Vermont-NEA
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists

Tuesday, January 30, 2018
Committee(s):
Senate Committee on Health and Welfare
11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
11:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Mark-up

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, Executive Director, Green Mountain Care Board

Friday, February 2, 2018
Committee(s):
Senate Committee on Health and Welfare
10:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Susan Barrett, Executive Director, Green Mountain Care Board
Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association

Tuesday, February 6, 2018
Committee(s):
Senate Committee on Health and Welfare
`

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion, Possible Mark-up and Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health

Wednesday, February 7, 2018
Committee(s):
Senate Committee on Health and Welfare
9:45 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion and Possible Vote

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services

Friday, February 9, 2018
Committee(s):
Senate Committee on Finance
2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk thru of bill by drafter

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines

Tuesday, February 13, 2018
Committee(s):
Senate Committee on Finance
2:30 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Possible Vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, February 23, 2018
Committee(s):
Senate Committee on Appropriations
1:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sen. Claire Ayer
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Thursday, March 15, 2018
Committee(s):
House Committee on Health Care
10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Walk-through with Legislative Counsel

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Continue walk-through of the bill.

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health

Thursday, March 22, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Overview; Sec. 1 of the bill--importation of prescription drugs; fiscal note.

Sen. Tim Ashe, Sponsor
John Tracy, Field Representative, Office of Senator Patrick Leahy
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Peter Welch, U.S. Congressman, Vermont
Trish Riley, Executive Director, National Academy of State Health Policy
Jane Horvath, National Academy of State Health Policy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Bernie Sanders, U.S. Senator
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, March 23, 2018
Committee(s):
House Committee on Health Care
8:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Background; prescription drug transparency; reports from the Attorney General's Office

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jill Abrams, Assistant Attorney General, Attorney General's Office

Wednesday, March 28, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Sec. 1, Importation of drugs, continued; Section 2, Bulk purchasing

Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
10:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Section 6: "Gag rule"

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jeff Hochberg, President, Vermont Retail Druggists
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Jamie Feehan, Lobbyist, CVS/Caremark
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare

Thursday, March 29, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Testimony on Sections 3 and 4 --Health Insurance Plan Reporting; Impact of Prescription Drug Costs on Health Insurance Premiums

Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Susan Barrett, Executive Director, Green Mountain Care Board
Kevin Mullin, Chair, Green Mountain Care Board

Wednesday, April 4, 2018
Committee(s):
House Committee on Health Care
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, April 5, 2018
Committee(s):
House Committee on Health Care
11:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Review draft and Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Wednesday, April 11, 2018
Committee(s):
House Committee on Health Care
9:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
10:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Discussion; follow-up from work group on current prescription drug pricing law.

Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Jill Abrams, Assistant Attorney General, Attorney General's Office
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Bridget Morris, Lobbyist, Association for Accessible Medicines

Thursday, April 12, 2018
Committee(s):
House Committee on Ways and Means
9:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Thursday, April 12, 2018
Committee(s):
House Committee on Health Care
3:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Focus on drug importation & bulk purchasing

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 13, 2018
Committee(s):
House Committee on Health Care
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion (S.262 discussion postponed to next week)

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
2:15 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Final markup and possible vote. S.175 only. Time changed to 2:15 PM or after discussion on S.92

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Wednesday, April 18, 2018
Committee(s):
House Committee on Ways and Means
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
3:15 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Al Gobeille, Secretary, Agency of Human Services
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Thursday, April 19, 2018
Committee(s):
House Committee on Ways and Means
After the Floor

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Friday, April 20, 2018
Committee(s):
House Committee on Ways and Means
9:15 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

potential vote

Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Friday, April 20, 2018
Committee(s):
House Committee on Health Care
--After the Floor

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Bill As Recommended by House Ways and Means Committee. https://legislature.vermont.gov/assets/Documents/2018/WorkGroups/House%20Health%20Care/Bills/S.175/S.175~House%20Ways%20and%20Means%20Committee~S.175,%20As%20Recommended%20by%20House%20Ways%20and%20Means%20Committee~4-20-2018.pdf

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Rep. George W. Till
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office

Tuesday, April 24, 2018
Committee(s):
House Committee on Health Care
1:00 PM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee discussion: Amendment from House Ways and Means

Rep. Mary S. Hooper, Sponsor of amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Wednesday, April 25, 2018
Committee(s):
House Committee on Appropriations
11:30 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Rep. William J. Lippert, Chair, House Committee on Health Care

Thursday, April 26, 2018
Committee(s):
Senate Committee on Health and Welfare
8:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Committee Discussion



Thursday, May 3, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council

Monday, May 7, 2018
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.175 - An act relating to the wholesale importation of prescription drugs into Vermont

Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Sen. Michael Sirotkin, Reporter, Senate Committee on Finance

An act relating to the wholesale importation of prescription drugs into Vermont

Witnesses Who Testified

2017-2018 Legislative Session
House Committee on Appropriations
  • Rep. William J. Lippert, Chair, House Committee on Health Care
House Committee on Health Care
  • Jill Abrams, Assistant Attorney General, Attorney General's Office
  • Sen. Tim Ashe, Sponsor
  • Susan Barrett, Executive Director, Green Mountain Care Board
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
  • Jamie Feehan, Lobbyist, CVS/Caremark
  • Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
  • Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
  • Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
  • Jeff Hochberg, President, Vermont Retail Druggists
  • Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
  • Rep. Mary S. Hooper, Sponsor of amendment
  • Jane Horvath, National Academy of State Health Policy
  • Theo Kennedy, Lobbyist, Vermont Retail Druggists
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
  • Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
  • Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
  • Bridget Morris, Lobbyist, Association for Accessible Medicines
  • Kevin Mullin, Chair, Green Mountain Care Board
  • Trish Riley, Executive Director, National Academy of State Health Policy
  • Bernie Sanders, U.S. Senator
  • Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
  • Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
  • Rep. George W. Till
  • John Tracy, Field Representative, Office of Senator Patrick Leahy
  • Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
  • Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
  • Peter Welch, U.S. Congressman, Vermont
House Committee on Ways and Means
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • Al Gobeille, Secretary, Agency of Human Services
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Senate Committee on Appropriations
  • Sen. Claire Ayer
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Senate Committee on Finance
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
  • Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
Senate Committee on Health and Welfare
  • Sen. Tim Ashe, Sponsor
  • Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
  • Susan Barrett, Executive Director, Green Mountain Care Board
  • Jennifer Carbee, Legislative Counsel, Office of Legislative Council
  • David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
  • Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
  • Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
  • Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
  • Mark Hage, Member Benefits Director, Vermont-NEA
  • Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
  • Jeff Hochberg, President, Vermont Retail Druggists
  • Theo Kennedy, Lobbyist, Vermont Retail Druggists
  • Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
  • Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
  • Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
  • Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
  • Kevin Mullin, Chair, Green Mountain Care Board
  • Trish Riley, Executive Director, National Academy of State Health Policy
  • Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
  • Sen. Michael Sirotkin, Reporter, Senate Committee on Finance
  • Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
  • John Tracy, Field Representative, Office of Senator Patrick Leahy
  • Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
  • Peter Welch, U.S. Congressman, Vermont

Back to top

Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill.  The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.

Fiscal Information

Fiscal Notes and Related Documents

Back to top

No committee of conference data found for S.175 in the 2017-2018 Legislative Session.

Act


Back to top

Staff & Other Information

Staff
Jennifer Carbee, Legislative Counsel

Back to top